drugset / Trial / NCT04147338
A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants
RandomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the serum concentration of guselkumab after administration using three different devices in healthy participants.
Timeline
- Start
- 2019-10-30
- Primary completion
- 2021-09-13
- Completion
- 2021-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.